# GPT-5-mini Review

**Role:** External referee review
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-04T03:06:02.716121
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 25213 in / 5787 out
**Response SHA256:** 2bb46e448e8c26a1

---

Summary
This is a careful, up-to-date empirical evaluation of states' extensions of Medicaid postpartum coverage from 60 days to 12 months. The paper exploits staggered adoption, ACS survey data 2017–2024 (excl. 2020), and a triple-difference / Callaway–Sant'Anna (CS-DiD) estimation strategy to isolate postpartum-specific effects from the large secular Medicaid "unwinding" shock after the COVID-era continuous-enrollment pause. The authors implement a compelling battery of inference procedures (cluster-robust SEs, wild cluster bootstrap, permutation inference by reassigning cohorts, Rambachan–Roth HonestDiD), attenuation calculations for ACS measurement, pre-trend tests, cohort-specific ATTs, leave-one-out control-state checks, and a power analysis. The chief empirical claim is: the standard DiD shows a statistically significant negative post‑PHE ATT (−2.18 pp) that reflects differential unwinding; the DDD (preferred) estimate is small, positive, and statistically insignificant (+0.99 pp, SE = 1.55 pp), so the data rule out large effects but cannot distinguish a modest positive effect from zero. The paper is relevant to policy and methodology in a post‑PHE evaluation environment.

Overall assessment (headline)
The paper is promising and contains many best-practice elements for a top applied empirical paper (heterogeneity-robust staggered DiD; careful inference for few clusters; sensitivity checks). However, substantial issues remain in transparency, robustness, and presentation that must be addressed before the paper is appropriate for a top general-interest journal. I recommend MAJOR REVISION. See decision line at the end.

Detailed review organized by your requested headings.

1. FORMAT CHECK (document structure, completeness, format problems)
- Length: The LaTeX source is extensive (many figures/tables and appendices). From the content, this will compile into a manuscript well above 25 pages (I estimate ~40–60 pages including main text and figures; main text likely >25 pages). That satisfies the page-length requirement for a top journal, but please ensure the main text (excluding appendix) remains focused and within typical AER/JPE length norms. Cite: whole document.
- References: The bibliography is extensive and includes most modern staggered DiD literature (Callaway & Sant'Anna 2021; Goodman‑Bacon 2021; Sun & Abraham 2021; Rambachan & Roth 2023; Ferman & Pinto 2021, etc.). The policy and health literatures cited are also strong. See Section: Bibliography. Minor gaps (see Section 4 below) need to be filled.
- Prose: Major sections (Introduction, Institutional Background, Conceptual Framework, Data, Empirical Strategy, Results, Discussion, Conclusion) are written as paragraphs, not bullets. Good. See Introduction (pp. 1–5).
- Section depth: Most major sections have multiple substantive paragraphs. For instance, Introduction (many paragraphs), Empirical Strategy (many paragraphs), Results (many subsections). Good. But some subsections in the Appendix are thin and could be consolidated or expanded where needed (e.g., Data Appendix variable construction is concise but ok).
- Figures: Figures are referenced and appear to be substantive (raw trends, event studies, permutation histogram, pre-trend DDD). But I cannot see the rendered images here. Please ensure in the final submission that every figure:
  - Shows actual data (no placeholder images),
  - Has labeled axes with units (percentage points for coverage rates),
  - Has legible fonts and captions that identify sample, N, and clustering.
  I note the captions do include some notes, but the submission must include raw-data point markers or clear lines and confidence bands. See Figures: fig2_raw_trends (Section 4), fig3_event_study (Section 6).
- Tables: The paper references many tables and inputs (\input statements). From the source, tables appear to have actual numbers, not placeholders (e.g., sample-size table in Appendix, many tabX files). Ensure all tables included in the compiled PDF contain numeric entries, standard errors, and sample sizes; the main tables need to report SEs/CIs, cluster count, and observation counts. See Tab2_main_results, Tab3_robustness, etc.

2. STATISTICAL METHODOLOGY (critical)
I treat this section as the gatekeeper: a paper cannot pass without proper statistical inference. You appear to address nearly all requirements, but please ensure the manuscript actually reports the items below in the tables and figures cited.

a) Standard errors
- The manuscript states standard errors and many places report SEs and/or CIs (e.g., DDD CS-DiD estimate +0.99 pp (SE = 1.55 pp); DiD −2.18 pp (SE = 0.74 pp)). All regression tables must display SEs (in parentheses) or 95% CIs besides point estimates. The text states "All regression tables now report 95% confidence intervals alongside point estimates." Make sure this is true in every main table. If some specifications use wild cluster bootstrap or permutation p-values, report both SEs and those alternative p-values in the tables or notes (so readers can see the usual SE-based interval and alternative inference).
- FAIL condition check: I do not detect any coefficient reported without SE/CIs/p-values in the main text; but ensure that all table cells do.

b) Significance testing
- The paper conducts standard inference and also permutation and wild cluster bootstrap. Good. For a top journal, please make available both conventional cluster-robust SEs and the WCB p-values side-by-side for the main columns (or at least as table notes).

c) Confidence intervals
- The abstract and text refer to 95% CIs and HonestDiD robust CIs. Ensure main tables list 95% CIs (or 90% where relevant) for main estimates. Explicitly show the DDD 95% CI (e.g., +0.99 ± 1.96×1.55 = approximately [−2.06, +4.04]) in the paper so readers can immediately see the inferential range.

d) Sample sizes
- The paper reports N for the overall sample (237,365 postpartum women) and subsamples. But each regression/table must report the number of observations and number of clusters (states) used. The text claims "All tables report the number of clusters used in each specification." Confirm that every main table has Obs and #clusters. In practice, many reviewers will look for these in the table footnotes.

e) DiD with staggered adoption
- PASS: The paper uses Callaway & Sant'Anna (2021) as the main staggered-DiD estimator; it also runs Sun & Abraham and Goodman‑Bacon decompositions. The authors explicitly avoid TWFE as primary and use CS-DiD and cohort-time aggregation. This addresses the primary danger of TWFE using already-treated units as controls. Good.

f) RDD requirements
- Not applicable (no RDD). No action needed.

Bottom-line on methodology: The authors have implemented appropriate heterogeneous-treatment staggered DiD estimators, extensive inference protections (permutation, wild bootstrap, reporting of CIs), and sensitivity analysis (HonestDiD). That substantially satisfies the "statistical-inference" gate—provided the tables actually display SEs/CIs and cluster counts everywhere and the permutation/wild-bootstrap procedures are reported with the exact implementation details (see constructive suggestions below). If any regression cell lacks SE/CI/p-value, the paper should be considered unpublishable until fixed.

3. IDENTIFICATION STRATEGY (credibility, assumptions, tests)
Strengths
- The paper recognizes the primary threat to identification (Medicaid unwinding), documents it, and motivates a DDD to absorb state-level secular shocks. This is a thoughtful empirical approach.
- The use of non-postpartum low‑income women as an internal control is plausible and is tested with a DDD pre-trend event study (Figure 8 / tab6_ddd_pretrend). The authors show the non-postpartum event study mirrors the negative dynamics, supporting the unwinding explanation.
- The use of CS-DiD on the differenced outcome is a neat way to marry DDD and staggered DiD heterogeneity-robust estimation.

Concerns / items requiring stronger evidence or clarity
- DDD identifying assumption: The DDD requires that the differential trend between postpartum and non-postpartum low-income women would have been the same in treated and control states absent treatment. The paper reports a DDD pre-trend event study and a joint F-test. Please do all of the following:
  - Report the numerical pre-trend coefficients, SEs, and the joint pre-trend p-value in the main text/table (you do have table tab6_ddd_pretrend in Appendix, but it should be clearly displayed and discussed in the main results).
  - Provide placebo lead tests (e.g., include multiple falsification leads) and report p-values for them.
  - Report balance tables comparing treated vs. control states on observables relevant to unwinding intensity (PHE-era enrollment growth; share increase in Medicaid during the PHE; procedural disenrollment rates if available) in pre-period. You have some balance tests, but expand them to include administrative unwinding intensity proxies (KFF or state redetermination processes).
- Thin control group: Only 4 "control" jurisdictions remain (AR, WI never-adopters; ID and IA adopting in 2025). This is a material limitation. The paper acknowledges it, runs leave-one-out checks, and uses permutation inference, but please:
  - Report the leave-one-out estimates in a clear table (I see tab8_loo included; place summary in main text).
  - Consider additional robustness: use synthetic-control-type weights to construct a better counterfactual from treated states that adopt later (i.e., treat late adopters as pseudo-controls), or re-run CS-DiD with alternative control sets (e.g., drop one or two treated cohorts and treat later adopters as controls) — present these as sensitivity checks. This helps address the concern that 4 control states may be idiosyncratic.
- Mechanism of unwinding: You convincingly show non-postpartum women in treated states experienced similar declines. Still, the policy implication depends on whether the postpartum extension affects continuity (coverage spells), not necessarily point-in-time coverage. The ACS cannot measure continuity. The paper stresses this limitation; however, to bolster identification it should:
  - Add more evidence linking state unwinding intensity to the negative DiD: e.g., regress the post-PHE DiD coefficient on state-level unwinding intensity measures (percent of enrollees disenrolled, or KFF redetermination metrics). If the negative DiD correlates with unwinding intensity, that strengthens the interpretation. The paper suggests "unwinding intensity analysis" in the title/footnote—report that explicitly in the main results.
- Heterogeneity: Cohort-specific ATTs are reported. Please ensure the paper documents which cohorts are driving the aggregate negative DiD (and whether those cohorts had higher PHE-era enrollment growth). This is necessary to complete the reconciliation story.

4. LITERATURE (missing references and how to integrate)
The paper cites the primary methodological literature for staggered DiD and HonestDiD. A few methodological/pedagogical references would strengthen the framing and show familiarity with evaluation best practices. I recommend adding these:

- Lee and Lemieux (2010) and Imbens & Lemieux (2008) for RDD — only if you discuss RDD or bandwidth/manipulation tests. If not using RDD, citing them is not required. Still, the paper mentions RDD tests in the review checklist; if an RDD is not used, no RDD refs are necessary.
- A paper that emphasizes interpretation of ITT/ATT scaling in repeated cross-sections or survey data attenuation might be helpful: Daw et al. (2020) is cited. Another relevant work on measurement attenuation in survey vs administrative data could be cited if available.
- Papers on permutation/randomization inference for policy evaluation with few treated groups could be highlighted—Conley & Taber (2011) and Ferman & Pinto (2021) are cited. Consider also Abadie et al. (2010) (synthetic control) is cited. Good.

Specific missing citations I recommend adding (and reasons). Provide BibTeX entries as requested.

1) Lee, David S., and Thomas Lemieux. 2010. "Regression Discontinuity Designs in Economics." Journal of Economic Literature. This is the canonical RDD review; even if you do not implement RDD, mentioning it would be useful if you discuss bandwidth/manipulation tests in the checklist (you currently do not). If you choose not to cite RDD literature because the paper does not use RDD, that's acceptable.

BibTeX:
```bibtex
@article{LeeLemieux2010,
  author = {Lee, David S. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs in Economics},
  journal = {Journal of Economic Literature},
  year = {2010},
  volume = {48},
  pages = {281--355}
}
```

2) Imbens, Guido W., and Thomas Lemieux. 2008. "Regression Discontinuity Designs: A Guide to Practice." Journal of Econometrics. (Again, RDD canonical reference; include only if relevant.)

BibTeX:
```bibtex
@article{ImbensLemieux2008,
  author = {Imbens, Guido W. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs: A Guide to Practice},
  journal = {Journal of Econometrics},
  year = {2008},
  volume = {142},
  pages = {615--635}
}
```

3) Abadie, Alberto, Alexis Diamond, and Jens Hainmueller (2010). You already cite this (good). Keep.

4) Ferman, Bruno, and Pinto (2021) and Conley & Taber (2011) are already cited (good).

5) A relevant paper on survey-administrative differences and measurement attenuation (to complement your attenuation calculation), e.g.:
- Huber, Matthew, and Hossein (if such exist). If no canonical paper, at minimum cite the Census / ACS documentation that explains FER and interview-month limitations. You include a Census API link; good. Also cite any KFF or MACPAC memo describing the limits of ACS for measuring enrollment dynamics.

6) Administrative-evidence papers on postpartum extensions: Krimmel et al. (2024) is cited; good. Also cite state-level evaluation papers if available (MACPAC or KFF policy notes are present).

In short: the methodological literature for staggered DiD is well-covered; add Lee & Lemieux / Imbens if you discuss RDD in the review checklist or reviewer concerns.

5. WRITING QUALITY (critical)
Positive points
- The paper tells a clear empirical story: unwinding confounds DiD, DDD resolves it, results are small/insignificant, administrative data needed for continuity. The narrative arc is coherent (motivation → institutional background → method → results → policy implication).
- The Introduction summarizes contributions and methods fairly transparently.

Issues to fix
- Density and repetition: Several paragraphs repeat the same logic (unwinding confound, DDD justification) across the Introduction, Conceptual Framework, Results, and Discussion. Tighten the manuscript to avoid redundancy.
- Footnote/dated claims: Footnote in Data says "The 2024 ACS 1-year PUMS was released by the Census Bureau in October 2025." That is anachronistic (date in the future relative to the paper's date) and looks like an artifact of autonomous generation. Remove or correct any incorrect dates. Review all footnotes for factual accuracy. (Cite: Data section, footnote.)
- Clarity for less-specialists: Some econometric terminology (e.g., "CS-DiD dynamic aggregation" vs "group-size aggregation") is explained but still technical. Consider adding a brief intuition box or one-paragraph plain-language description in the Empirical Strategy for non-specialists about what CS-DiD does and why it matters.
- Paragraph openings: Key insights should be front-loaded in paragraphs. Sometimes the first sentence is a restatement and the substantive result appears later. Tighten prose.
- Tables/Figures self-contained: Ensure each figure/table has a complete note explaining sample, variable definitions, number of clusters, and how SEs/CIs were computed. For example, event-study figures should state whether CIs are cluster-robust, WCB, or permutation-based.
- Disclosure of code/data: The paper gives a GitHub link. For top journals, make ready-to-run replication code and data-extraction scripts available and document the computational intensity of the permutation/re-estimation (how long did 1,000 CS-DiD permutations take?). Provide a README in the repo describing random seeds and package versions.

6. CONSTRUCTIVE SUGGESTIONS (to increase impact and credibility)
The paper is already methodologically rich; the following suggestions will substantially strengthen it and address reviewer concerns.

A. Transparency / reproducibility
- Provide the exact code for: (i) how "treated" is coded by state-year (provide a table mapping state → adoption date used in coding), (ii) the CS-DiD calls and aggregation choices, (iii) the permutation procedure (how cohort-size distribution is preserved, random seed used).
- Include an online appendix with full att_gt() ATT(g,t) matrices for each outcome so reviewers can inspect cell-level estimates that drive aggregates.
- Include run time information for permutation and bootstrap procedures.

B. Strengthen identification vs. thin control group
- Augment the leave-one-out analysis with synthetic-control‑style robustness: create a synthetic control for treated states using weighted combinations of late adopters / never-adopters where possible. Alternatively, run a staggered DiD that treats 2024 adopters as not-yet-treated in earlier years (placebo control set) as a robustness check.
- Use continuous measures of unwinding intensity (e.g., state-level percent change in Medicaid enrollment from May 2023 to March 2024 from KFF/ASPE) and show that the negative DiD is correlated with unwinding intensity. If the negative DiD is concentrated in states with high unwinding, that reinforces your interpretation.
- Provide an analysis that uses alternative comparison groups: e.g., compare postpartum women to low‑income men aged 18–44 as an additional DDD group (if plausible) to test whether results hinge on the choice of non‑postpartum women.

C. Measurement and attenuation
- The analytic attenuation calibration is helpful. Complement it with a simulation or micro-simulation: generate synthetic birth-months for ACS respondents under plausible distributions and simulate how a true effect on fully-exposed women maps into observed ITT in ACS using your exact adoption-date distribution. Present a figure showing mapping from true effect → expected ITT estimate. This will be more persuasive than the analytic back-of-envelope alone.
- If possible, cross-validate your ACS-based estimates with any available administrative data in a subset of states (if authors can access public state-level enrollment series). Even a descriptive correlation between the direction/magnitude of administrative enrollment changes and your ACS-based estimates would help.

D. Inference details and presentation
- In main tables, present: (i) cluster-robust SE in parentheses, (ii) WCB p‑value in brackets, (iii) permutation p‑value in a separate column or note, and (iv) number of clusters and observations. This avoids readers having to flip to the appendix.
- For the DDD primary result, explicitly show the 95% CI (point estimate ± margin) in the main text and in the abstract (if space allows).
- Report joint tests of pre-period coefficients (with p-values) both for CS‑DiD and the DDD differenced outcome in the main Results section.

E. Heterogeneity and policy relevance
- Emphasize subgroup estimates where the policy plausibly matters most (very low-income, Medicaid-eligible women, race/ethnicity groups). If the DDD effect for, say, very-low-income women is larger (even imprecise), discuss it explicitly.
- Discuss the interpretation in terms of continuity vs. point-in-time coverage much earlier (in Introduction). Many policymakers will be more interested in continuity and maternal outcomes than a single cross-sectional coverage rate.

F. Alternative specifications and robustness to weighting
- Check sensitivity to weighting by person weights vs. unweighted regressions. ACS weights are appropriate, but show that results are robust to weighting scheme.
- Evaluate robustness to inclusion of state-specific linear trends (with caution, since these can absorb treatment effects). Present these as sensitivity checks, not main results.
- Consider re-running the DDD as an individual-level regressions with state × postpartum and year × postpartum FE (you do this), but show the equivalence/relationship to the CS-DiD differenced approach and discuss any differences.

G. Clarity on the permutation procedure
- The paper says permutations preserve cohort-size distribution and reassign states to cohorts. State this explicitly (you do in Appendix) and provide a short diagnostic figure showing the randomized distribution of ATT under permutations. You already include a histogram; please annotate it with the observed ATT and exact p-value.

7. OVERALL ASSESSMENT

Key strengths
- Thoughtful recognition of a major post‑PHE empirical confound (Medicaid unwinding) and explicit design to address it (DDD + CS‑DiD on differenced outcome).
- Use of modern staggered DiD methods (Callaway & Sant'Anna) and a rich battery of inference tools (permutation, WCB, HonestDiD).
- Comprehensive robustness checks (leave-one-out control states, cohort-specific ATTs, pre-trend tests, late-adopter analyses).
- Helpful discussion of the limits of ACS (attentuation) and the policy relevance of continuity vs. point-in-time coverage.

Critical weaknesses (must be addressed)
- Thin control group (4 states) remains a core limitation. The paper acknowledges it, but reviewers will push hard for either stronger robustness that mitigates this concern (synthetic control / alternative control sets / unwinding intensity analyses) or more explicit discussion of the external validity problem.
- DDD identifying assumption needs clearer, more prominently displayed diagnostics (numerical pre-trend joint test results, placebo leads, balance on unwinding intensity).
- Some key tables/figures must explicitly present SEs/CIs and cluster counts in the main text (ensure complete reporting).
- Prose needs tightening; remove anachronistic or spurious footnotes and ensure all factual statements have correct dates and citations.
- Administrative data / coverage‑continuity measures would be much more informative. The paper argues for administrative data as a next step—if the authors can obtain even limited administrative evidence for a subset of states, it would greatly strengthen the paper.

Specific suggestions for improvement (short list)
1. Add explicit table in main text listing all states, adoption dates used for coding, and cohort membership.
2. Add a table summarizing ATT(g,t) matrix (group × time cell-level) in the main appendix and discuss which cells drive the aggregate ATT.
3. Report pre-trend joint test p-values for the DDD differenced outcome prominently (not only in appendix).
4. Show correlation between state-level unwinding intensity (from KFF/ASPE) and the negative DiD / cohort-specific ATTs to demonstrate the unwinding mechanism empirically.
5. Provide simulation mapping true fully-exposed effects → observed ACS ITT estimates using the actual distribution of adoption dates and ACS interview timing assumptions.
6. Present main DDD result with three inference measures in the main table: cluster-robust SE, WCB p-value, permutation p-value.
7. Tighten prose, remove repetitive paragraphs, and correct any factual anomalies (dates, footnotes).

8. DECISION (required)
- After addressing the points above, the paper could be suitable for a major journal. The current submission is not yet ready.

DECISION: MAJOR REVISION

Appendix: Additional recommended BibTeX entries you requested (two key methodological references)
- Lee & Lemieux (2010)
```bibtex
@article{LeeLemieux2010,
  author = {Lee, David S. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs in Economics},
  journal = {Journal of Economic Literature},
  year = {2010},
  volume = {48},
  pages = {281--355}
}
```

- Imbens & Lemieux (2008)
```bibtex
@article{ImbensLemieux2008,
  author = {Imbens, Guido W. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs: A Guide to Practice},
  journal = {Journal of Econometrics},
  year = {2008},
  volume = {142},
  pages = {615--635}
}
```

(If you do not use RDD methods, you may omit these citations; I include them only because the review checklist asked for canonical methodology citations.)

Final note: This is an important empirical question for maternal health policy, and the authors have constructed a strong methodological toolkit. With the suggested additional diagnostics addressing the thin-control issue and clearer reporting of inferential procedures/results in the main tables, the paper will be substantially stronger and more convincing for a top general-interest journal.